Skip to main content

BioVie Inc. (NASDAQ: BIVI) Investor Securities Class Action Lawsuit 01/19/2024

  • If you purchased a significant amount of shares of BioVie Inc. (NASDAQ: BIVI) between August 5, 2021 and November 29, 2023, and / or if you purchased any NASDAQ: BIVI shares prior to August 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 19, 2024. NASDAQ: BIVI investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 19, 2024 - An investor in shares of BioVie Inc. (NASDAQ: BIVI) filed a lawsuit in the U.S. District Court for the District of Nevada over alleged violations of Federal Securities Laws by BioVie Inc. in connection with certain allegedly false and misleading statements made between August 5, 2021 and November 29, 2023. Carson City, NV based BioVie Inc., a clinical stage biopharm...

You must register (for free) or login to view the entire case.